Description
Tirzepatide Disposable Pen — Opti-Gen Peptides
Laboratory accessory kit. For research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.
Not a patient injection device.
Empty disposable pen body supplied in a fitted case with four 4 mm needle attachments, branded Opti-Gen Peptides. Sold only as a laboratory handling accessory. It does not contain tirzepatide unless a separate RUO article is purchased and documented on its own COA.
Licensed tirzepatide products are prescription-only medicines. This kit is not those products. Must not be used to administer substances to people or animals.
Identification
| Product name | Tirzepatide Disposable Pen (accessory kit) |
| Supplier | Opti-Gen Peptides |
| Contents | 1 × empty disposable pen body; 4 × 4 mm needle attachments; fitted case |
| Peptide fill | None in this kit unless stated on a separate lot COA |
| Related research peptide (sold separately) | Tirzepatide (CAS 2023788-19-2) |
| Intended use | Laboratory accessory only |
Not Mounjaro. Not Zepbound. Not semaglutide. Not retatrutide.
Quality / storage
Store dry as laboratory hardware. No assembly, priming, click-count, units or administration instructions on this page. Needles are not supplied for clinical or consumer injection.
Published research context (not product claims)
Tirzepatide is a dual GIP / GLP-1 receptor analogue. Receptor papers describe dual-agonist pharmacology in experimental systems.
Clinical-development programmes produced authorised medicines. Those authorisations apply only to approved drug products and licensed pens.
SURPASS / SURMOUNT-type publications concern licensed presentations. They must not be rewritten as weight-loss or diabetes claims for this accessory kit.
There is no authorisation to market this kit as a UK medicine or patient device.
UK notice
18+. Buyer confirms lawful laboratory use only and will not use or resell this kit for unauthorised human or animal administration.
Reviews
There are no reviews yet.